Drug Target Review2024-12-31T08:00:39
MIT's new open-source AI model, Boltz-1, could transform drug discovery by accurately predicting protein structures, offering global access to researchers.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2026-06-15T11:00:00
Sponsored by Miltenyi Biotec
2023-03-20T13:41:33
Sponsored by Bio-Techne
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
Site powered by Webvision Cloud